Atrioventricular block medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:
* [[Anti-cholinergic drug]]
* [[Anti-cholinergic drug]]
* Improves AV conduction
* Improves AV conduction
* Insufficient doses can worsen the block.
* Insufficient doses can worsen the block
====Isoproterenol====
====Isoproterenol====
* [[Isoproterenol]] is a beta 1 and beta 2 receptor agonist.
* [[Isoproterenol]] is a beta 1 and beta 2 receptor agonist
* Increases [[heart rate]]
* Increases [[heart rate]]
* [[Ionotropic effect]]
* [[Ionotropic effect]]

Revision as of 17:54, 8 February 2013

Atrioventricular block Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrioventricular block from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Atrioventricular block medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atrioventricular block medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrioventricular block medical therapy

CDC on Atrioventricular block medical therapy

Atrioventricular block medical therapy in the news

Blogs on Atrioventricular block medical therapy

Directions to Hospitals Treating Atrioventricular block

Risk calculators and risk factors for Atrioventricular block medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Treatment goal is to remove the extrinsic causes and treat reversible intrinsic causes. Drugs used in the treatment of AV nodal blocks include atropine, isoproterenol, theophylline, antibiotics treatment for lyme disease and treatment of ischemia. A permanent pacemaker is indicated for symptomatic bradycardia due to advanced second- or third-degree heart blocks.

Medical Therapy

  • Permanent pacemaker is the treatment of choice for atrioventricular blocks and does not require concomitant pharmacologic treatment.
  • Drugs that block AV nodal conduction must be discontinued.

Emergency Management

  • Atropine may be administered in emergency management of atrioventricular block to improve AV conduction until a temporary transcutaneous or transvenous pacemaker is inserted. However, atropine can potentially worsen the conduction if the block is in the bundle of His.

Atropine

Isoproterenol

Follow-up

References

Template:WH Template:WS